Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC48436
4'-Acetylchrysomycin B
A bacterial metabolite with antibacterial and anticancer activities
-
GC48434
Elsinochrome A
痂囊腔菌素AELSINOCHROMEA
A fungal metabolite -
GC48433
BX-320
N1-[3-[[5-溴-2-[[3-[(1-吡咯烷基羰基)氨基]苯基]氨基]-4-嘧啶基]氨基]丙基]-2,2-二甲基丙烷二酰胺
An inhibitor of PDK1 -
GC48430
Ac-DEVD-CMK (trifluoroacetate salt)
AcAspGluValAspCMK, Caspase3 Inhibitor III
An inhibitor of caspase-3 -
GC48423
19-O-Acetylchaetoglobosin A
Chaetoglobosin A Acetate
A fungal metabolite with actin polymerization inhibitory and cytotoxic activities -
GC48418
N-(2-Poc-ethyl)betulin amide
An alkyne derivative of betulin
-
GC48409
Burnettramic Acid A aglycone
A fungal metabolite with anticancer activity
-
GC48406
PSI (trifluoroacetate salt)
Proteasome Inhibitor I, Z-Ile-Glu(OtBu)-Ala-Leu-aldehyde, Z-Ile-Glu(OtBu)-Ala-Leu-CHO
A proteasome inhibitor -
GC48401
Risuteganib (trifluoroacetate salt)
ALG-1001
An anti-integrin peptide -
GC48399
MTP 131 (acetate)
Elamipretide, SS-31
A mitochondria-targeted peptide antioxidant -
GC48392
CAY10747
An inhibitor of the Hsp90-Cdc37 protein-protein interaction
-
GC48387
Inostamycin A
A bacterial metabolite with anticancer activity
-
GC48376
Burnettramic Acid A
A fungal metabolite with diverse biological activities
-
GC48374
Saikosaponin D (hydrate)
A triterpene saponin with diverse biological activities
-
GC48356
Psychotridine
An alkaloid with diverse biological activities
-
GC48354
Stephacidin B
(-)-Stephacidin B
A fungal metabolite -
GC48350
Amycolatopsin C
A polyketide macrolide with antimycobacterial and anticancer activities
-
GC48341
Amycolatopsin B
A bacterial metabolite
-
GC48339
Amycolatopsin A
A macrolide polyketide with antimycobacterial and anticancer activities
-
GC48335
N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)
GM3-Neugc, NeuGc-GM3, NGcGM3, N-glycolyl-GM3, N-glycolyl-Monosialoganglioside GM3, N-Glycolylneuraminyllactosylceramide
A mixture of N-glycolyl-ganglioside GM3 -
GC48292
α-MSH (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)
Α-促黑激素,α-Melanocyte-Stimulating Hormone TFA
A peptide hormone -
GC48261
XTT (sodium salt hydrate)
A cell-impermeable, negatively charged tetrazolium dye
-
GC48258
Xanthoquinodin A1
Xanthoquinidone C
A fungal metabolite with diverse biological activities -
GC48247
Verrucarin A
疣孢菌素,Muconomycin A
A macrocyclic trichothecene with diverse biological activities -
GC48230
Ursodeoxycholic Acid-d4
3β-熊去氧胆酸 d4
An internal standard for the quantification of ursodeoxycholic acid -
GC48210
TRX-818 (sodium salt)
An anticancer compound
-
GC48202
Treprostinil (diethanolamine salt)
曲前列尼尔二乙醇胺盐,UT-15C
An agonist of IP2, DP2, and EP2 receptors -
GC48195
trans-trismethoxy Resveratrol-d4
(E)-5-2-(4-hydroxyphenyl)ethenyl-1,3-benzene diol-d4, TMS-d4, trans-3,5,4'-Trimethoxystilbene-d4
An internal standard for the quantification of trans-trismethoxy resveratrol -
GC48165
Thiocoraline
PM 93135
A depsipeptide and DNA bis-intercalator with antibacterial and anticancer activities -
GC48135
Tebufenozide
虫酰肼
An insecticide and ecdysone receptor agonist -
GC48124
Tamoxifen-d5
ICI 47699-?d5; (Z)-Tamoxifen-?d5; trans-Tamoxifen-?d5
An internal standard for the quantification of tamoxifen -
GC48119
Suprafenacine
SML1493
An inhibitor of tubulin polymerization with anticancer activity -
GC48118
Sunitinib-d10
舒尼替尼-D10,SU 11248-d10
An internal standard for the quantification of sunitinib -
GC48099
SR 12460
An IKKβ NBD mimetic
-
GC48098
SR 12343
An IKKβ NBD mimetic
-
GC48096
Sporogen-AO 1
(+)-Sporogen-AO 1
A fungal metabolite with diverse biological activities -
GC48084
Sodium 4-Phenylbutyrate-d11
4-PBA-d11 sodium; 4-Phenylbutyric acid-d11 sodium; Benzenebutyric acid-d11 sodium
An internal standard for the quantification of sodium 4-phenylbutyrate -
GC48076
Sesquicillin A
Sesquicillin
A fungal metabolite -
GC48028
Rasagiline-13C3 (mesylate)
甲磺酸雷沙吉兰-13C3
An internal standard for the quantification of rasagiline -
GC48027
Rapamycin-d3
三氘代雷帕霉素,Sirolimus-d3; AY-22989-d3
An internal standard for the quantification of rapamycin -
GC48022
Radotinib-d6
IY-5511
Radotinib-d6 是氘标记的 Radotinib。 -
GC48020
Quercetin-d3 (hydrate)
A neuropeptide with diverse biological activities
-
GC48019
Quercetin (hydrate)
槲皮素二水合物
A flavonoid with diverse biological activities -
GC47972
Previridicatumtoxin
A fungal metabolite with diverse biological activities
-
GC47955
Phloroglucinol
间苯三酚
A phenol with diverse biological activities -
GC47923
Paraxanthine-d6
1,7-Dimethylxanthine-d6
An internal standard for the quantification of paraxanthine -
GC47853
Paclitaxel-d5
紫杉醇 d5
An internal standard for the quantification of paclitaxel -
GC47818
Oleic Acid-d17
cis-9-Octadecenoic Acid-d17
An internal standard for the quantification of oleic acid -
GC47805
N-Phenylthiourea
苯基硫脲
A tyrosinase inhibitor and building block -
GC47803
Noscapine-13C-d3
Narcotine-13C-d3, Opianine-13C-d3
An internal standard for the quantification of noscapine